Aevi Genomic Medicine Competitors and Similar CompaniesClear all

Aevi Genomic Medicine's competitors and similar companies include AnGes, Intellia Therapeutics and CRISPR Therapeutics.

	Aevi Genomic Medicine Aevi Genomic Medicine is a clinical stage biopharmaceutical company.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date	Founding Date 2000	Founding Date 1999	Founding Date 2014	Founding Date 2013
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Wayne, US HQ San Francisco, US	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations Cambridge, US HQ	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US
Employees	Employees 1418% decrease	Employees 5562% decrease	Employees 40323% decrease	Employees 393
Valuation ($)	Valuation ($) N/A	Valuation ($) 78.3 m	Valuation ($) 1.7 b	Valuation ($) 4.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) $3.5m (FY, 2025)
Net income	Net income ($30.8m) (FY, 2018)	Net income (¥5.1b) (FY, 2025)	Net income ($412.7m) (FY, 2025)	Net income ($581.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 7m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 127m